Summary: Signifier Medical Technologies has launched a new hardware remote control (SKU 18010) for its eXciteOSA sleep apnea therapy, aligning with CMS requirements to facilitate Medicare and Medicaid reimbursement and expanding patient access to treatment.
Signifier Medical Technologies Ltd has introduced a new SKU, 18010, which features a hardware remote control designed to meet Centers for Medicare & Medicaid Services (CMS) requirements for reimbursement. This means eXciteOSA daytime obstructive sleep apnea therapy can be more readily accessed by Medicare and Medicaid patients.
“eXciteOSA is a life-changing device helping patients address a root cause of sleep apnea and other sleep disorders,” says Mujtaba Chohan, head of finance and director at Signifier, in a release. “This milestone underscores our ongoing commitment to innovation, as well as our determination to expand treatment access through alignment with CMS requirements.”
Yasser Zayni, head of commercial, clinical, and compliance at Signifier, says in a release, “The introduction of this new remote control allows us to reach more patients, through Medicare and Medicaid, who desperately need alternative therapies for their sleep apnea….With this new SKU 18010, we’re building on that progress, ensuring Medicare and Medicaid patients across the country have access to this innovative, user-friendly therapy.”
eXciteOSA Update Details
- Medicare and Medicaid Reimbursement: By introducing this hardware remote control, Signifier has met the criteria to classify its eXciteOSA therapy under CMS HCPCS Codes (E0490 and E0491).
- Hardware Innovation: The remote control simplifies device usage for patients, offering a user-friendly interface that aligns with the durable medical equipment (DME) requirements set forth by Medicare and Medicaid.
- Consistent, Effective Treatment Experience: The new remote control maintains the same clinically proven efficacy and convenience that patients expect from eXciteOSA.
